These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19072879)

  • 1. Effects of levosimendan on left atrial functions in patients with ischemic heart failure.
    Duygu H; Nalbantgil S; Ozerkan F; Zoghi M; Akilli A; Erturk U; Akin M; Nazli C; Ergene O
    Clin Cardiol; 2008 Dec; 31(12):607-13. PubMed ID: 19072879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of levosimendan versus dobutamine on left atrial function in decompensated heart failure.
    Duman D; Palit F; Simsek E; Bilgehan K; Sacide A
    Can J Cardiol; 2009 Oct; 25(10):e353-6. PubMed ID: 19812809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Levosimendan versus dobutamine in heart failure patients treated chronically with carvedilol.
    Duygu H; Turk U; Ozdogan O; Akyuz S; Kirilmaz B; Alioglu E; Gunduz R; Bozkaya YT; Turkoglu C; Payzin S
    Cardiovasc Ther; 2008; 26(3):182-8. PubMed ID: 18786088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of sustained effects of levosimendan and dobutamine on left ventricular systolic functions by using novel tissue Doppler derived indices in patients with advanced heart failure.
    Oner E; Erturk M; Birant A; Kurtar Mansıroglu A; Akturk IF; Karakurt H; Yalcin AA; Uzun F; Somuncu MU; Yildirim A
    Cardiol J; 2015; 22(1):87-93. PubMed ID: 24846511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of levosimendan on E/E' ratio in patients with ischemic heart failure.
    Duygu H; Ozerkan F; Nalbantgil S; Zoghi M; Akilli A; Akin M; Nazli C; Ergene O
    Int J Cardiol; 2008 Jan; 123(2):201-3. PubMed ID: 17316845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dobutamine-induced changes of left atrial two-dimensional deformation predict clinical and neurohumoral improvement after levosimendan treatment in patients with acutely decompensated chronic heart failure.
    Paraskevaidis IA; Ikonomidis I; Parissis J; Papadopoulos C; Stassinos V; Bistola V; Anastasiou-Nana M
    Int J Cardiol; 2012 May; 157(1):31-7. PubMed ID: 21176979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term levosimendan treatment improves systolic function and myocardial relaxation in mice with cardiomyocyte-specific disruption of the Serca2 gene.
    Hillestad V; Kramer F; Golz S; Knorr A; Andersson KB; Christensen G
    J Appl Physiol (1985); 2013 Nov; 115(10):1572-80. PubMed ID: 24072410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Levosimendan restores the positive force-frequency relation in heart failure.
    Masutani S; Cheng HJ; Tachibana H; Little WC; Cheng CP
    Am J Physiol Heart Circ Physiol; 2011 Aug; 301(2):H488-96. PubMed ID: 21572004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of levosimendan and dobutamine on QRS duration in patients with heart failure.
    Yontar OC; Yilmaz MB; Yalta K; Erdem A; Tandogan I
    Arq Bras Cardiol; 2010 Dec; 95(6):738-42. PubMed ID: 21109913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levosimendan on right ventricular systolic and diastolic functions in patients with ischaemic heart failure.
    Duygu H; Ozerkan F; Zoghi M; Nalbantgil S; Yildiz A; Akilli A; Akin M; Nazli C; Ergene O
    Int J Clin Pract; 2008 Feb; 62(2):228-33. PubMed ID: 17949428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Levosimendan improves renal function in patients with acute decompensated heart failure: comparison with dobutamine.
    Yilmaz MB; Yalta K; Yontar C; Karadas F; Erdem A; Turgut OO; Yilmaz A; Tandogan I
    Cardiovasc Drugs Ther; 2007 Dec; 21(6):431-5. PubMed ID: 17952581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative effects of levosimendan, OR-1896, OR-1855, dobutamine, and milrinone on vascular resistance, indexes of cardiac function, and O2 consumption in dogs.
    Banfor PN; Preusser LC; Campbell TJ; Marsh KC; Polakowski JS; Reinhart GA; Cox BF; Fryer RM
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H238-48. PubMed ID: 17982006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dobutamine and nitroprusside infusion in patients with severe congestive heart failure: hemodynamic improvement by discordant effects on mitral regurgitation, left atrial function, and ventricular function.
    Capomolla S; Pozzoli M; Opasich C; Febo O; Riccardi G; Salvucci F; Maestri R; Sisti M; Cobelli F; Tavazzi L
    Am Heart J; 1997 Dec; 134(6):1089-98. PubMed ID: 9424070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemia-modified albumin levels in patients with acute decompensated heart failure treated with dobutamine or levosimendan: IMA-HF study.
    Çavuşoğlu Y; Korkmaz Ş; Demirtaş S; Gencer E; Şaşmaz H; Mutlu F; Güneş H; Mert UK; Özdemir S; Kalaycı S; Yılmaz MB
    Anatol J Cardiol; 2015 Aug; 15(8):611-7. PubMed ID: 26301344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of dobutamine-induced changes of the two-dimensional longitudinal deformation predict clinical and neurohumoral improvement in men after levosimendan treatment in acutely decompensated chronic heart failure.
    Paraskevaidis IA; Bistola V; Ikonomidis I; Parissis JT; Papadopoulos C; Filippatos G; Kremastinos DT
    Am J Cardiol; 2008 Nov; 102(9):1225-9. PubMed ID: 18940297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of ischemic side effects of levosimendan and dobutamine with integrated backscatter analysis.
    Duygu H; Nalbantgil S; Zoghi M; Ozerkan F; Yildiz A; Akilli A; Akin M
    Clin Cardiol; 2009 Apr; 32(4):187-92. PubMed ID: 19353707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of levosimendan in comparison and in combination with dobutamine in the treatment of decompensated heart failure.
    Cavusoglu Y
    Expert Opin Pharmacother; 2007 Apr; 8(5):665-77. PubMed ID: 17376021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiotonic drugs differentially alter cytosolic [Ca2+] to left ventricular relationships before and after ischemia in isolated guinea pig hearts.
    Chen Q; Camara AK; Rhodes SS; Riess ML; Novalija E; Stowe DF
    Cardiovasc Res; 2003 Oct; 59(4):912-25. PubMed ID: 14553831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.
    Dominguez-Rodriguez A; Samimi-Fard S; Garcia-Gonzalez MJ; Abreu-Gonzalez P
    Int J Cardiol; 2008 Aug; 128(2):214-7. PubMed ID: 17643535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of levosimendan versus dobutamine on inflammatory and apoptotic pathways in acutely decompensated chronic heart failure.
    Adamopoulos S; Parissis JT; Iliodromitis EK; Paraskevaidis I; Tsiapras D; Farmakis D; Karatzas D; Gheorghiade M; Filippatos GS; Kremastinos DT
    Am J Cardiol; 2006 Jul; 98(1):102-6. PubMed ID: 16784930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.